Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$96.14 - $147.2 $2.43 Million - $3.72 Million
-25,300 Reduced 84.33%
4,700 $677 Million
Q2 2025

Aug 14, 2025

BUY
$64.81 - $105.9 $1.94 Million - $3.18 Million
30,000 New
30,000 $3.02 Billion

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $26.2B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Sig Brokerage, LP Portfolio

Follow Sig Brokerage, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sig Brokerage, LP, based on Form 13F filings with the SEC.

News

Stay updated on Sig Brokerage, LP with notifications on news.